Verily, formerly Google Life Sciences, is an Alphabet company combining a data-driven, people-first approach to bring the promise of precision health to everyone, every day.

Verily develops tools and devices to collect, organize and activate health data, and creates interventions to prevent and manage disease. 

Verily was formerly a division of Google X until 10 August 2015, and become an independent subsidiary of Alphabet in Oct 2015. The company is headquartered in South San Francisco, with multiple offices worldwide.

Verily is focused on generating and applying evidence from a wide variety of sources to change the way people manage their health and the way healthcare is delivered - shifting the paradigm from “one size fits all” medicine to one focused on a more comprehensive view of the individual that leads to a more personalized path forward.

Verily expanded the reach of its virtual clinic, called Onduo, into multiple chronic conditions and also launched digital services geared toward mental and behavioral health. The company also launched a stop-loss insurance company, which it has rebranded as Granular.

Verily collaborates with world renowned organizations committed to making a positive impact on human health. Some of its partners include 3M, Alcon, Allergan, Atrius Health, Colgate, GSK, Mayo Clinick, P&G, & Standford Medicine.

Verily is backed by Alphabet, Silver Lake Partners, Temasek Holdings, and Ontario Teachers' Pension Plan, and others. The company raised $1B in a new round on Sep 09, 2022. This brings Verily's total funding to $3.5B to date. The company didn't disclose its valuation for the latest round but was last valued at over $10M from a funding raised Dec 2020